Findings underscore the importance of anxiety and worry for women's cognitive performance at midlife among APOE4 carriers. They suggest the potential value of treating anxiety symptoms in APOE4 carriers to support women's cognition at midlife and beyond.
Harrison et al. (Fri,) studied this question.